当前位置: X-MOL 学术Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Clinical outcomes and immunological features of COVID-19 patients receiving B-cell depletion therapy during the Omicron era
Infectious Diseases ( IF 5.8 ) Pub Date : 2023-12-18 , DOI: 10.1080/23744235.2023.2276784
Chan Mi Lee 1 , Minji Kim 2, 3, 4 , Seong-wook Park 5 , Chang Kyung Kang 1 , Pyoeng Gyun Choe 1 , Nam Joong Kim 1 , Hyeon Jae Jo 1 , Hyun Mu Shin 2, 4, 6 , Chang-Han Lee 2, 4, 5, 6, 7 , Hang-Rae Kim 2, 3, 4, 6, 8 , Wan Beom Park 1 , Myoung-don Oh 1
Affiliation  

Background: The clinical outcomes and immunological features of coronavirus disease 2019 (COVID-19) patients receiving B-cell depletion therapy (BCDT), especially in Omicron variant era, have not b...

中文翻译:

Omicron 时代接受 B 细胞耗竭治疗的 COVID-19 患者的临床结果和免疫学特征

背景:接受 B 细胞耗竭疗法 (BCDT) 的 2019 冠状病毒病 (COVID-19) 患者的临床结果和免疫学特征,尤其是在 Omicron 变异时代,尚未得到证实。
更新日期:2023-12-18
down
wechat
bug